Lensar (LNSR) Long-Term Investments (2023 - 2024)

Lensar (LNSR) posted quarterly Long-Term Investments of $494000.0 for Q3 2024, down 59.97% quarter-over-quarter from $1.2 million in Q2 2024.

Lensar (LNSR) Long-Term Investments (2023 - 2024) Analysis & Trends

Lensar (LNSR) has reported Long-Term Investments for 2 consecutive years, with $494000.0 the latest figure, recorded in Q3 2024.

In Q3 2024, Long-Term Investments changed N/A year-over-year to $494000.0; the TTM figure through Sep 2024 stood at $494000.0 (changed N/A YoY), while the FY2023 annual figure was $492000.0, changed N/A from the prior year.
Long-Term Investments eased to $494000.0 in Q3 2024 per LNSR's latest filing, from $1.2 million in the prior quarter.
Across five years, Long-Term Investments topped out at $1.2 million in Q1 2024 and bottomed at $492000.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	1.11 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	-
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	-
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	2.25 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	244.10 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	-
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	175.52 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	-
10	Lensar	103.79 Mn	90.22 Mn	9.78 Mn	-

Download Data